BAGNOLINI, GRETA
 Distribuzione geografica
Continente #
AS - Asia 1.929
EU - Europa 1.173
NA - Nord America 963
SA - Sud America 172
AF - Africa 77
OC - Oceania 31
Totale 4.345
Nazione #
US - Stati Uniti d'America 918
IT - Italia 650
CN - Cina 552
SG - Singapore 428
VN - Vietnam 347
HK - Hong Kong 152
BR - Brasile 143
KR - Corea 114
DE - Germania 112
IN - India 98
GB - Regno Unito 65
FR - Francia 62
BD - Bangladesh 59
NL - Olanda 59
JP - Giappone 53
AU - Australia 31
CI - Costa d'Avorio 30
IE - Irlanda 30
FI - Finlandia 28
SE - Svezia 26
CA - Canada 24
ES - Italia 23
PK - Pakistan 20
IR - Iran 19
RU - Federazione Russa 18
DK - Danimarca 17
MX - Messico 16
TW - Taiwan 16
CH - Svizzera 15
PH - Filippine 14
AT - Austria 13
AR - Argentina 12
EG - Egitto 12
PL - Polonia 12
TG - Togo 10
HR - Croazia 9
TH - Thailandia 9
TR - Turchia 9
ZA - Sudafrica 8
ID - Indonesia 7
JO - Giordania 6
MA - Marocco 6
BG - Bulgaria 5
BY - Bielorussia 5
IQ - Iraq 5
PT - Portogallo 5
PY - Paraguay 5
CZ - Repubblica Ceca 4
AE - Emirati Arabi Uniti 3
EC - Ecuador 3
GR - Grecia 3
IL - Israele 3
MY - Malesia 3
NG - Nigeria 3
UA - Ucraina 3
UZ - Uzbekistan 3
VE - Venezuela 3
BE - Belgio 2
CL - Cile 2
CO - Colombia 2
DZ - Algeria 2
HN - Honduras 2
HU - Ungheria 2
OM - Oman 2
PE - Perù 2
SA - Arabia Saudita 2
SM - San Marino 2
AM - Armenia 1
CG - Congo 1
CR - Costa Rica 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
JM - Giamaica 1
LT - Lituania 1
MM - Myanmar 1
MU - Mauritius 1
MW - Malawi 1
NP - Nepal 1
RO - Romania 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
Totale 4.345
Città #
Singapore 313
Hefei 199
Ashburn 174
Bologna 169
Hong Kong 131
Hanoi 99
Ho Chi Minh City 96
Seoul 86
San Jose 70
Milan 67
Beijing 46
Tokyo 43
Fairfield 36
Florence 36
Los Angeles 35
Rome 34
Santa Clara 34
Abidjan 30
Dublin 30
Chandler 29
Council Bluffs 28
Frankfurt am Main 27
Seattle 27
Lauterbourg 26
Sydney 26
Houston 25
New York 24
São Paulo 24
Dallas 23
Falkenstein 22
Bengaluru 21
Helsinki 21
Genoa 16
Southend 16
Cambridge 15
Da Nang 15
Buffalo 14
Jalandhar 14
Redmond 14
Woodbridge 14
Munich 13
Haiphong 12
Jhelum 12
Modena 12
Nanjing 12
Shanghai 12
Verona 12
Amsterdam 11
Boardman 11
Copenhagen 11
Forlì 11
Vienna 11
Lomé 10
Stockholm 10
Toronto 10
Turin 10
Boston 9
Brooklyn 9
Calcinelli 9
Claymont 9
London 9
Mexico City 9
Naples 9
Porto Alegre 9
Redondo Beach 9
Chicago 8
Philadelphia 8
Rimini 8
Tianjin 8
Wilmington 8
Biên Hòa 7
Guangzhou 7
Hyderabad 7
Minneapolis 7
Montreal 7
Zurich 7
Athens 6
Atlanta 6
Barcelona 6
Berlin 6
Düsseldorf 6
Madrid 6
Madīnat an Naşr 6
Nijmegen 6
Nuremberg 6
Palermo 6
Phoenix 6
Piacenza 6
Princeton 6
Tehran 6
Wuhan 6
Zagreb 6
Amman 5
Brescia 5
Chennai 5
Denver 5
Jakarta 5
Johannesburg 5
Lisbon 5
Lucca 5
Totale 2.648
Nome #
Design and synthesis of small molecules targeting pre-miRNA21 toward the development of ribonuclease targeting chimeras (RIBOTACs) to regulate the oncogenic miRNA21 371
Synthetic Lethality in Pancreatic Cancer: Discovery of a New RAD51-BRCA2 Small Molecule Disruptor That Inhibits Homologous Recombination and Synergizes with Olaparib 276
Rad51/Brca2 Disruptors Inhibit Homologous Recombination and Synergize with Olaparib in Pancreatic Cancer Cells 275
A journey through targeting BRCA2-RAD51 protein-protein interaction to establish synthetic lethality as paradigm for anticancer drug discovery 262
Insights into the activity of ARN24089, a new RAD51-BRCA2 disruptor that inhibits homologous recombination and achieves synthetic lethality in pancreatic cancer 253
New Horizons of Synthetic Lethality in Cancer: Current Development and Future Perspectives 243
Investigating synthetic lethality and PARP inhibitor resistance in pancreatic cancer through enantiomer differential activity 239
Targeting RNA degradation with small molecules: design and synthesis of selective RNA binders and development of ribonuclease targeting chimeras (RIBOTACs) 220
An 19F NMR fragment-based approach for the discovery and development of BRCA2-RAD51 inhibitors to pursuit synthetic lethality in combination with PARP inhibition in pancreatic cancer 211
Inhibition of Urease, a Ni-Enzyme: The Reactivity of a Key Thiol With Mono- and Di-Substituted Catechols Elucidated by Kinetic, Structural, and Theoretical Studies 207
Differential enantiomers activity of ARN24089 to achieve synthetic lethality in pancreatic cancer 197
Design and synthesis of RAD51-BRCA2 protein-protein interaction disruptors to trigger synthetic lethality with Olaparib in pancreatic cancer cells 189
Design and synthesis of RAD51-BRCA2 disruptors to inhibit homologous recombination and achieve synthetic lethality in pancreatic cancer cells 177
Dihydroquinoline pyrazoline-based compound as a new RAD51-BRCA2 protein-protein disruptor to trigger synthetic lethality in pancreatic cancer 163
Identification of RAD51-BRCA2 Inhibitors Using N-Acylhydrazone-Based Dynamic Combinatorial Chemistry 159
Design and synthesis of RAD51-BRCA disruptors to inhibit homologous recombination and achieve synthetic lethality in cancer cells 122
Design and synthesis of BRCA2-RAD51 disruptors to induce synthetic lethality in anticancer therapy 118
Design and synthesis of small molecules binders of pre-miRNA21 toward the regulation of oncogenic miRNA21 118
Triggering RNA degradation with small molecules: development of RIBOnuclease TArgeting Chimeras (RIBOTACs) 108
Targeting RAD51-BRCA2 Interaction to Enhance Synthetic Lethality with Olaparib in Pancreatic Cancer: Development of a Novel Phenyl Furan-Quinoline-Carboxylic Acid Series 87
Design and synthesis of BRCA2-RAD51 disruptors to induce synthetic lethality in cancer treatment 84
DESIGN AND SYNTHESIS OF SMALL MOLECULES TARGETING PRE-MIRNA21 TOWARD THE DEVELOPMENT OF RIBONUCLEASE TARGETING CHIMERAS (RIBOTACS) TO REGULATE THE ONCOGENIC MIRNA21 80
Design and synthesis of BRCA2-RAD51 disruptors to induce synthetic lethality in anticancer therapy 77
Identification of RAD51-BRCA2 inhibitors using N-acylhydrazone-based dynamic combinatorial chemistry 67
Design and synthesis of RAD51-BRCA2 disruptors to inhibit homologous recombination and synergize with Olaparib as new anticancer drug discovery concept 60
Recognizing the power of machine learning and other computational methods to accelerate progress in small molecule targeting of RNA 44
Totale 4.407
Categoria #
all - tutte 9.361
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.361


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 0 0 0 0 0 5
2021/202291 10 4 4 3 5 5 7 14 8 5 12 14
2022/2023142 8 19 7 17 10 9 7 10 21 10 8 16
2023/2024236 11 9 4 7 18 19 21 7 10 18 70 42
2024/2025939 47 33 35 22 85 71 57 21 61 126 132 249
2025/20262.829 301 328 251 332 240 122 248 144 424 140 156 143
Totale 4.407